Changes in brain lipid metabolism have been reported for many common neurodegenerative diseases such as Alzheimer’s disease, ALS, Parkinson’s but also other rare diseases such as Batten Disease or Niemann Pick’s. Disease-modifying treatments for many of these diseases are lacking, but based on the genetics lipid-targeting interventions could be developed to prevent, delay or cure these disorders.